DLRHX
Price
$25.94
Change
+$0.05 (+0.19%)
Updated
Oct 17 closing price
Net Assets
678.66M
FSPHX
Price
$28.71
Change
+$0.03 (+0.10%)
Updated
Oct 17 closing price
Net Assets
5.96B
Interact to see
Advertisement

DLRHX vs FSPHX

Header iconDLRHX vs FSPHX Comparison
Open Charts DLRHX vs FSPHXBanner chart's image
Macquarie Healthcare R
Price$25.94
Change+$0.05 (+0.19%)
VolumeN/A
Net Assets678.66M
Fidelity Select Health Care
Price$28.71
Change+$0.03 (+0.10%)
VolumeN/A
Net Assets5.96B
DLRHX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
DLRHX vs. FSPHX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLRHX is a Hold and FSPHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 5.96B vs. DLRHX (679M). FSPHX pays higher dividends than DLRHX: FSPHX (0.02) vs DLRHX (0.00). DLRHX was incepted earlier than FSPHX: DLRHX (16 years) vs FSPHX (44 years). DLRHX (1.51) is less costly to investors than FSPHX (0.63). FSPHX is a more actively managed with annual turnover of: 40.00 vs. DLRHX (5.00). DLRHX (0) and FSPHX (0) have matching initial minimum investment requirements. DLRHX (-9.11) and FSPHX (-9.34) have marching annual gain over last year. DLRHX return over 5 years is better than : -4.99 vs. FSPHX (-13.17).
DLRHXFSPHXDLRHX / FSPHX
Total Expense Ratio1.460.63232%
Annual Report Gross Expense Ratio1.510.63240%
Fund Existence16 years44 years-
Gain YTD12.6365.248241%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets679M5.96B11%
Annual Yield % from dividends0.000.02-
Returns for 1 year-9.11-9.3498%
Returns for 3 years4.138.1651%
Returns for 5 years-4.99-13.1738%
Returns for 10 years32.9138.7085%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRCAX121.950.42
+0.35%
Harbor Capital Appreciation Admin
PIUIX26.59N/A
N/A
Federated Hermes International Equity IS
GGOSX10.79N/A
N/A
Goldman Sachs Mid Cap Growth Svc
FWATX15.74N/A
N/A
Fidelity Advisor Multi-Asset Income A
DCDGX12.81-0.12
-0.93%
Dunham Small Cap Growth C